{"version":"1.0","provider_name":"Prokrea","provider_url":"https:\/\/prokreabcn.com\/en\/","author_name":"dept.ti","author_url":"https:\/\/prokreabcn.com\/en\/author\/patbender\/","title":"Innovation - Prokrea","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"AJxSux3GGe\"><a href=\"https:\/\/prokreabcn.com\/en\/innovation\/\">Innovation<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/prokreabcn.com\/en\/innovation\/embed\/#?secret=AJxSux3GGe\" width=\"600\" height=\"338\" title=\"&#8220;Innovation&#8221; &#8212; Prokrea\" data-secret=\"AJxSux3GGe\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"PROKREA ha desarrollado un nuevo tratamiento para la infertilidad por factor masculino leve basada en la administraci\u00f3n postcoital de un gel vaginal de pentoxifilina reposicionado que actualmente est\u00e1 indicado para el tratamiento de la salud vascular y cuya actividad in vitro en el incremento de la motilidad esperm\u00e1tica est\u00e1 bien caracterizada. El objetivo es mejorar la movilidad esperm\u00e1tica facilitando la fecundaci\u00f3n y ofrecer una nueva v\u00eda terap\u00e9utica para el tratamiento de la infertilidad por factor masculino leve.","thumbnail_url":"https:\/\/prokreabcn.com\/wp-content\/uploads\/elementor\/thumbs\/63-r78w7fxfyg72vq2yamd7dnmjn4fsgruqzsn8upfqkg.png"}